A 15-month-old dachshund was presented for examination because of a cough. Thoracic radiographs revealed the presence of a mass in the upper mediastinum. A diagnosis of gammadelta T-cell lymphoma was made by biopsy and flow cytometry analysis. The dog was treated with chemotherapy and remains asymptomatic after 24 months.

Lymphome T gamma-delta chez un chien. Un Dachshund âgé de 15 mois est présenté pour examen en raison d’une toux. Des radiographies du thorax ont révélé la présence d’une masse dans le médiastin supérieur. Un diagnostic de lymphome T γδ est posé suite à une biopsie et une analyse par cytométrie en flux. Le chien a été traité avec de la chimiothérapie et demeure asymptomatique après 24 mois. (Traduit par Isabelle Vallières)

Clinic of Dog and Cat Diseases University of Veterinary and Pharmaceutical Sciences Palackeho 1 3 612 42 Czech Republic

See more in PubMed

Ponce F, Magnol JP, Ledieu D, et al. Prognostic significance of morphologic subtypes in canine malignant lymphomas during chemotherapy. Vet J. 2004;167:158–166. PubMed

Ruslander DA, Gebhard DH, Tompkins MB, Grindem CB, Page RL. Immunophenotypic characterization of canine lymphoproliferative disorders. In Vivo. 1997;11:169–172. PubMed

Dobson JM, Blackwood LB, McInnes EF. Prognostic variables in canine multicentric lymphosarcoma. J Small Anim Pract. 2001;42:377–384. PubMed

Veldt BJ, Meijers C, Zondervan PE, de Man RA. Hepatosplenic γδ T cell lymphoma: A diagnostic pitfall. J Hepatol. 2003;39:455–457. PubMed

Meulenbeld HJ, Spiering W, Nooijen P, Peters W, Creemers GJ. Hepatosplenic gammadelta T-cell lymphoma: A case report. Eur J Intern Med. 2007;18:241–243. PubMed

Fry MM, Vernau W, Pesavento PA, Bromel C, Moore PF. Hepatosplenic lymphoma in a dog. Vet Pathol. 2003;40:556–562. PubMed

Faldyna M, Sinkora J, Knotigova P, Leva L, Toman M. Lymphatic organ development in dogs: Major lymphocyte subsets and activity. Vet Immunol Immunopathol. 2005;104:239–247. PubMed

Owen LN. TNM Classification of Tumours in Domestic Animals. Geneva: World Health Organization; 1980. pp. 46–47.

Garrett LD, Thamm DH, Chun R, Dudley R, Vail DM. Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med. 2002;16:704–709. PubMed

Plumb JA, Luo W, Kerr DJ. Effect of polyunsaturated fatty acids on the drug sensitivity of human tumor cell lines resistant to either cisplatin or doxorubicin. Br J Cancer. 1993;67:728–733. PubMed PMC

Ogilvie GK, Fettman MJ, Mallinckrodt CH, et al. Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma: A double-blind, randomized placebo-controlled study. Cancer. 2000;88:1916–1928. PubMed

Kaiser HE. Animal neoplasms — comparative pathology in animals, plants and man . Baltimore: Williams and Wilkins; 1981. pp. 747–812.

Teske E. Canine malignant lymphoma: A review and comparison with human non-Hodgkin’s lymphomas. Vet Quat. 1994;16:209–219. PubMed

Phillips BS, Kass PH, Naydan DK, Winthrop MD, Griffey SM, Madewell BR. Apoptotic and proliferation indexes in canine lymphoma. J Vet Diagn Invest. 2000;12:111–117. PubMed

Siedlecki CT, Kass PH, Jakubiak MJ, Dank G, Lyons J, Kent MS. Evaluation of an actinomycin-D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma. Can Vet J. 2006;47:52–59. PubMed PMC

Culmsee K, Simon D, Mischke R, Nolte I. Possibilities of flow cytometric analysis for immunophenotypic characterization of canine lymphoma. J Vet Med A Physiol Pathol Clin Med. 2001;48:199–206. PubMed

Picker LJ, Brenner MB, Michie S, Warnke RA. Expression of T cell receptor delta chains in benign and malignant T lineage lymphoproliferations. Am J Pathol. 1988;132:401–405. PubMed PMC

Taguchi A, Miyazaki M, Sakuragi S, Shinohara K, Kamei T, Inoue Y. Gamma/delta T cell lymphoma. Intern Med. 2004;43:120–125. PubMed

Moore PF, Rossitto PV, Olivry T. Development of monoclonal antibodies to canine T cell receptor-1 (TCR-γδ) and their utilization in the diagnosis of epidermotropic cutaneous T cell lymphoma. Vet Pathol. 1994;31:597.

Vega F, Medeiros LJ, Gaulard P. Hepatosplenic and other gammadelta T-cell lymphomas. Am J Clin Pathol. 2007;127:869–880. PubMed

Delves PJ, Roitt IM. The immune system. First of two parts. N Engl J Med. 2000;343:37–49. PubMed

Faldyna M, Leva L, Knotigova P, Toman M. Lymphocyte subsets in peripheral blood of dogs-a flow cytometric study. Vet Immunol Immunopathol. 2001;82:23–37. PubMed

Groh V, Porcelli S, Fabbi M, et al. Human lymphocytes bearing T cell receptor γ/δ are phenotypically diverse and evenly distributed throughout the lymphoid system. J Exp Med. 1989;169:1277–1294. PubMed PMC

Farcet JP, Gaulard P, Marolleau JP, et al. Hepatosplenic T-cell lymphoma: Sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood. 1990;75:2213–2219. PubMed

Gaulard P, Belhadj K, Reyes F. Gamma delta T-Cell lymphomas. Semin Hematol. 2003;40:233–243. PubMed

Greer JP, Kinney MC, Loughran TP. T cell and NK cell lymphoproliferative disorders. Hematology. 2001:259–281. PubMed

Scolnik MP, Burgos RA, Paz A, et al. Nonhepatosplenic gamma delta T-cell lymphoma with initial testicular compromise. Am J Hematol. 2000;65:260–262. PubMed

Wei SZ, Liu TH, Wang DT, Cao JL, Luo YF, Liang ZY. Hepatosplenic gammadelta T-cell lymphoma. World J Gastroenterol. 2005;11:3729–3734. PubMed PMC

MacDonald VS, Thamm DH, Kurzman ID, Turek MM, Vail DM. Does L-asparaginase influence efficacy or toxicity when added to a standard CHOP protocol for dogs with lymphoma? J Vet Intern Med. 2005;19:732–736. PubMed

Jeffreys AB, Knapp DW, Carlton WW, et al. Influence of asparaginase on a combination chemotherapy protocol for canine multicentric lymphoma. J Am Anim Hosp Assoc. 2005;41:221–226. PubMed

Jagielski D, Lechowski R, Hoffmann-Jagielska M, Winiarczyk S. A retrospective study of the incidence and prognostic factors in multicentric lymphoma in dogs (1998–2000) J Vet Med A Physiol Pathol Clin Med. 2002;49:419–424. PubMed